Enanta Pharmaceuticals
ENTA
#8126
Rank
S$0.46 B
Marketcap
S$16.01
Share price
3.31%
Change (1 day)
7.50%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Net assets

Net assets on the balance sheet as of June 2026 : S$0.12 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company has S$0.12 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Enanta Pharmaceuticals - Net assets on balance sheet (from 2011 to 2026)

Net assets by year

Year Net assets Change
2025-09-30$S$83.49 M-49.56%
2024-09-30$S$0.16 B-44.09%
2023-09-30$S$0.29 B-35.81%
2022-09-30$S$0.46 B-14.98%
2021-09-30$S$0.54 B-12.74%
2020-09-30$S$0.62 B-2.74%
2019-09-30$S$0.63 B18.76%
2018-09-30$S$0.53 B31.28%
2017-09-30$S$0.41 B11.33%
2016-09-30$S$0.36 B9.55%
2015-09-30$S$0.33 B77.24%
2014-09-30$S$0.18 B36.79%
2013-09-30$S$0.13 B156.83%
2012-09-30$S$53.98 M89.33%
2011-09-30$S$28.51 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
S$108.79 B 83,973.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$53.70 B 41,402.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
-S$7.54 Billion-5,925.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$25.92 B 19,933.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$53.75 B 41,440.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$28.57 B 21,983.15%๐Ÿ‡บ๐Ÿ‡ธ USA